Newsroom

Tom Flottman’s firm, Flottman Co., produces pharmaceutical inserts and faces potential job losses due to a proposed bill favoring electronic over paper materials. Flottman argues that paper inserts are essential for patient safety and disaster scenarios. Losing this business line could result in significant staff reductions and impact specialized production techniques. Read the whole here. Read More

Finch Paper opposes a proposed law allowing drug makers to provide information online instead of in printed form with prescriptions. CEO Deba Mukherjee argues that this could hurt their business and hinder access to vital drug information. U.S. Rep. Bill Owens shares these concerns, aiming to address the issue during the legislative process. Read the… Read More

Governor Paul R. LePage urged the U.S. House to remove provisions in H.R. 1919 that would risk 600 Maine jobs. The bill mandates electronic labeling for pharmaceutical drugs, potentially eliminating 600 positions at Twin Rivers Paper Mill. LePage emphasized the economic impact and the potential challenges for seniors accessing online information. Read the whole article… Read More

The U.S. House of Representatives passed a bill targeting prescription drug fraud, but it faced opposition from Finch Paper due to an “anti-paper provision” mandating electronic invoicing. The bill aimed to standardize medicine tracking and enhance patient safety, but drew criticism for its potential impact on the paper industry and access to vital healthcare information… Read More

Opponents: Switching to Electronic Drug Info Could Imperil Maine Paper Jobs. Read More